{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:55:31Z","timestamp":1793739331377,"version":"4.6.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.cpcardiol.2022.101245","type":"journal-article","created":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T09:41:37Z","timestamp":1652002897000},"page":"101245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock"],"prefix":"10.1016","volume":"48","author":[{"given":"Suman","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaqib H","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0709-4324","authenticated-orcid":false,"given":"Dhrubajyoti","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Briasoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg M.","family":"Lanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srihari S","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"S3","key":"10.1016\/j.cpcardiol.2022.101245_bib0001","doi-asserted-by":"crossref","first-page":"III6","DOI":"10.1002\/clc.4960231503","article-title":"The economic burden of heart failure","volume":"23","author":"O'Connell","year":"2000","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101245_bib0002","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021061","article-title":"Fifteen-year trends in incidence of cardiogenic shock hospitalization and in-hospital mortality in the United States","volume":"10","author":"Osman","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2022.101245_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001462","article-title":"Effect of cardiogenic shock hospital volume on mortality in patients with cardiogenic shock","volume":"4","author":"Shaefi","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2022.101245_bib0004","doi-asserted-by":"crossref","first-page":"e71659","DOI":"10.1371\/journal.pone.0071659","article-title":"The effectiveness of inodilators in reducing short term mortality among patients with severe cardiogenic shock: a propensity-based analysis","volume":"8","author":"Pirracchio","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cpcardiol.2022.101245_bib0005","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American heart association","volume":"136","author":"Van Diepen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2022.101245_bib0006","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0002-8703(96)90315-4","article-title":"Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure","volume":"132","author":"Marius-Nunez","year":"1996","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2022.101245_bib0007","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0002-8703(99)70108-0","article-title":"Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial","volume":"138","author":"Oliva","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2022.101245_bib0008","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1067\/mhj.2001.119610","article-title":"Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: hemodynamic efficacy, clinical outcome, and economic impact","volume":"142","author":"Yamani","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2022.101245_bib0009","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-Hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications","volume":"46","author":"Abraham","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101245_bib0010","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/CIRCHEARTFAILURE.108.839076","article-title":"Prognosis on chronic dobutamine or milrinone infusions for stage d heart failure","volume":"2","author":"Gorodeski","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cpcardiol.2022.101245_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2008.01.015","article-title":"Resource utilization in patients hospitalized with heart failure: Insights from a contemporary national hospital database","volume":"155","author":"Hauptman","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2022.101245_bib0012","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/FJC.0000000000000811","article-title":"Comparison of positive inotropic agents in the management of acute decompensated heart failure","volume":"75","author":"Kelly","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cpcardiol.2022.101245_bib0013","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/1074248418797357","article-title":"Comparative effectiveness and safety between milrinone or dobutamine as initial inotrope therapy in cardiogenic shock","volume":"24","author":"Lewis","year":"2018","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.cpcardiol.2022.101245_bib0014","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1056\/NEJMoa2026845","article-title":"Milrinone as compared with dobutamine in the treatment of cardiogenic shock","volume":"385","author":"Mathew","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101245_bib0015","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1007\/s00134-016-4449-6","article-title":"Milrinone for cardiac dysfunction in critically ill adult patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis","volume":"42","author":"Koster","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cpcardiol.2022.101245_bib0016","article-title":"Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial","volume":"25","author":"Di Santo","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2022.101245_bib0017","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1067\/mhj.2003.50","article-title":"Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial","volume":"145","author":"Aranda","year":"2003","journal-title":"Am Heart J"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280622001426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280622001426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:43:08Z","timestamp":1758940988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280622001426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0146280622001426"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101245","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101245"}}